Ftse Mib
33.762,25
-0,83%
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
NASDAQ
17.948,32
-0,36%
Bitcoin
62.972,17
-0,64%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Olema Pharmaceuticals Inc (OLMA) Olema Pharmaceuticals Inc (OLMA) Notizie

Olema Pharmaceuticals Inc

OLMA
13,64
0,04 (0,29%)
21 Set 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/9/202422:49GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
21/8/202413:00GLOBEOlema Oncology to Participate in Morgan Stanley 22nd Annual..
06/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:10EDGAR2Form 8-K - Current report
06/8/202422:02GLOBEOlema Oncology Reports Second Quarter 2024 Financial Results..
05/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
31/7/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:15EDGAR2Form 144 - Report of proposed sale of securities
29/7/202422:23EDGAR2Form 144 - Report of proposed sale of securities
12/7/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202418:59EDGAR2Form 144 - Report of proposed sale of securities
02/7/202422:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:39EDGAR2Form 8-K - Current report
07/6/202400:49EDGAR2Form SC 13D/A - General statement of acquisition of..
06/6/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202416:05EDGAR2Form 144 - Report of proposed sale of securities
06/6/202416:02EDGAR2Form 144 - Report of proposed sale of securities
05/6/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:28GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
04/6/202421:09EDGAR2Form 144 - Report of proposed sale of securities
03/6/202420:55EDGAR2Form 144 - Report of proposed sale of securities
31/5/202418:17EDGAR2Form 144 - Report of proposed sale of securities
28/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202413:03GLOBEOlema Oncology to Participate in Upcoming Investor..
15/5/202413:06EDGAR2Form 8-K - Current report
15/5/202413:01GLOBEOlema Oncology Announces Promising New Data for Palazestrant..
08/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:06EDGAR2Form 8-K - Current report
08/5/202422:02GLOBEOlema Oncology Reports First Quarter 2024 Financial Results..
08/5/202413:02GLOBEOlema Oncology Announces New Clinical Data for Palazestrant..
07/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:00EDGAR2Form 144 - Report of proposed sale of securities
02/5/202422:37GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/5/202413:02GLOBEOlema Oncology to Participate in Upcoming Investor..
08/4/202422:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
02/4/202422:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
11/3/202421:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:05EDGAR2Form 8-K - Current report
11/3/202421:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
06/3/202413:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
04/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
29/2/202420:26EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 13,53 Min: 13,39 Max: 13,85
Chiusura: 13,60

La tua Cronologia

NASDAQ
OLMA
Olema Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network